23rd June 2021

Adapting and evolving – how the Diabetes Research Group Swansea Laboratory is continuing vital diabetes research through the pandemic

The last year has been a huge challenge for every area of health and care research, with many professionals facing redeployment on to urgent public health studies relating to COVID-19. The Diabetes Research Group Swansea Laboratory, part funded by Health and Care Research Wales, was no different. The team had to adapt key projects whilst…

23rd June 2021

NHS Wales Contract Award For Yourgene Health

Molecular diagnostics group Yourgene Health has been awarded a contract to supply its Elucigene DPYD testing kits to NHS Wales. The contract award is for up to two years and is estimated to be worth £232,000. The Elucigene DPYD1 screens cancer patients prior to the start of treatment with chemotherapeutic drug 5-Fluorouracil, to identify the…

23rd June 2021

Simbec Orion Announces Chief Operating Officer Appointment

I am delighted to announce that Ian Fraser will join Simbec-Orion as Chief Operating Officer on July 1st.  As COO, Ian will lead the Clinical Development division and the cross- divisional Biometrics, Regulatory Affairs & Technical Writing, and Pharmacovigilance teams.  Ian will also join the Board of Directors, as well as the Senior Leadership Team….

21st June 2021

Software Upgrade Allows Water Purification In China

The whole company at GX has been involved from the start of the project, several years ago, to design and development a reliable online analytical toxicity machine. To date GX has built over 70 Microtox® CTM machines. Following the machines success in tracing contaminated water in Asia the company Modern Water has expanded into China…

17th June 2021

Successful First In-Human use For Creo Device

Creo Medical Group has hailed the first in-human use of US Food & Drug Administration-cleared device which was successful in adding months to a patient’s life expectancy and well-being. The Chepstow-headquartered business’ MicroBlate Fine product was used in endoscopic ultrasound (EUS) guided, treatment in a patient with an unresectable pancreatic neuroendocrine tumour. Following the procedure,…

17th June 2021

GS Verde Group Expands into Ireland

Fast-growth multi-discipline GS Verde Group has announced further expansion, with the opening of its’ first office outside of the UK, with the launch of GS Verde (Ireland) in Dublin. The new office is located in Dublin 2, Dublin’s premier business district, and follows client led demand with both new and existing client agreements in the…

16th June 2021

The General Data Protection Regulation (GDPR): A look at the past, the present and the future

Already 5 years have passed since the vote of the European Parliament in April 2016. Yet, today many companies are still trying to understand how to best implement the General Data Protection Regulation (GDPR). Here is the article summarizing the important events and overall global impact that took place over these past 3 years since…

16th June 2021

Welsh MedTech Firm Nominated for ‘Nobel Prize’ for Engineering

Welsh MedTech innovation revolutionising cancer care announced as one of three finalists for most prestigious UK engineering award Creo Medical, the company behind an innovative and disruptive new suite of advanced energy, minimally invasive electrosurgical devices, has been named as one of three companies shortlisted for the 2021 MacRobert Award. The Chepstow based business designs…

16th June 2021

Medical School set to welcome students as Canadian partnership grows

Swansea University is building on its successful collaboration with Trent University in Canada to launch an additional opportunity for transatlantic study. Swansea has already established a dual degree arrangement in law and chemical engineering with the Ontario university. That is now set to be extended to include a dual degree pathway into undergraduate programmes at…

16th June 2021

Diagnostics and Life Sciences Firm Sold in £400M Deal

Mario Gualano, group chief executive of BBI Group A deal has been agreed for the sale of a South Wales-headquartered supplier of products and services to the diagnostics and life sciences industries for an enterprise value in excess of £400m. Private equity firm Exponent has reached an agreement to sell BBI Group  to Novo Holdings A/S,…